Global Neurorehabilitation

Neurorehabilitation Comprehensive Study by Type (Traumatic Brain Injury (TBI), Acquired Brain Injury (ABI)), Application (General Hospital, Rehabilitation Specialist Hospital, Community Rehabilitation Center), Rehabilitation (Medical, Vocational, Social, Physhological), Components (Cognitive Rehabilitation, Physical Rehabilitation, Occupational Therapy) Players and Region - Global Market Outlook to 2026

Neurorehabilitation Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Neurorehabilitation Market Scope?
Rehabilitation is the branch of medicine aiming to restore function and enhance the quality of life of those with impairments or disabilities. Neurorehabilitation is a complex medical process that aims to aid recovery from a nervous system injury and to minimize of compensating for any functional alterations resulting from it, it is the clinical subspecialty devoted to the restoration and maximization of functions that have been lost due to impairments caused by injury or disease of the nervous system. The research study shows that about 40% of major chronic disability is due to neurological disorders. Neurological rehabilitation awareness is an important and fascinating sub-specialty, which is attracting increasing interest from clinicians and managers alike.

The Neurorehabilitation market study is being classified by Type (Traumatic Brain Injury (TBI) and Acquired Brain Injury (ABI)), by Application (General Hospital, Rehabilitation Specialist Hospital and Community Rehabilitation Center) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions expansions investments new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies Analysts at AMA predicts that Players from China will contribute to the maximum growth of Global Neurorehabilitation market throughout the predicted period.

VISHEE (China), Beijing Bo'ai Hospital (China), Beijing Rehabilitation Hospital of Capital Medical University (China), Tongji Hospital (China), DIH (Netherlands), Xiangyu Medical(China), Sant Joan de Déu (Spain) and Clinique Valmont (Switzerland) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Neurorehabilitation market by Type, Application and Region.

On the basis of geography, the market of Neurorehabilitation has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Influencing Market Trend
  • Technological advancements

Market Drivers
  • Increasing awareness regarding the benefits of neurorehabilitation
  • The rise in geriatric population worldwide

Opportunities
  • Increasing prevalence and incidence rates of neurological disorders
  • The Asia Pacific is growing at the highest

Restraints
  • Insufficient disposable income
  • The cost of a health issue is not sufficient to attract clinicians to train in the area

Challenges
  • Awareness of neurorehabilitation and the size, develop research, set up services


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Neurorehabilitation Providers, Government Regulatory and Research Organizations and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Traumatic Brain Injury (TBI)
  • Acquired Brain Injury (ABI)
By Application
  • General Hospital
  • Rehabilitation Specialist Hospital
  • Community Rehabilitation Center
By Rehabilitation
  • Medical
  • Vocational
  • Social
  • Physhological

By Components
  • Cognitive Rehabilitation
  • Physical Rehabilitation
  • Occupational Therapy

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing awareness regarding the benefits of neurorehabilitation
      • 3.2.2. The rise in geriatric population worldwide
    • 3.3. Market Challenges
      • 3.3.1. Awareness of neurorehabilitation and the size, develop research, set up services
    • 3.4. Market Trends
      • 3.4.1. Technological advancements
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Neurorehabilitation, by Type, Application, Rehabilitation, Components and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Neurorehabilitation (Value)
      • 5.2.1. Global Neurorehabilitation by: Type (Value)
        • 5.2.1.1. Traumatic Brain Injury (TBI)
        • 5.2.1.2. Acquired Brain Injury (ABI)
      • 5.2.2. Global Neurorehabilitation by: Application (Value)
        • 5.2.2.1. General Hospital
        • 5.2.2.2. Rehabilitation Specialist Hospital
        • 5.2.2.3. Community Rehabilitation Center
      • 5.2.3. Global Neurorehabilitation by: Rehabilitation (Value)
        • 5.2.3.1. Medical
        • 5.2.3.2. Vocational
        • 5.2.3.3. Social
        • 5.2.3.4. Physhological
      • 5.2.4. Global Neurorehabilitation Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Neurorehabilitation: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. VISHEE (China)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Beijing Bo'ai Hospital (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Beijing Rehabilitation Hospital of Capital Medical University (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Tongji Hospital (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. DIH (Netherlands)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Xiangyu Medical(China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sant Joan de Déu (Spain)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Clinique Valmont (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Neurorehabilitation Sale, by Type, Application, Rehabilitation, Components and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Neurorehabilitation (Value)
      • 7.2.1. Global Neurorehabilitation by: Type (Value)
        • 7.2.1.1. Traumatic Brain Injury (TBI)
        • 7.2.1.2. Acquired Brain Injury (ABI)
      • 7.2.2. Global Neurorehabilitation by: Application (Value)
        • 7.2.2.1. General Hospital
        • 7.2.2.2. Rehabilitation Specialist Hospital
        • 7.2.2.3. Community Rehabilitation Center
      • 7.2.3. Global Neurorehabilitation by: Rehabilitation (Value)
        • 7.2.3.1. Medical
        • 7.2.3.2. Vocational
        • 7.2.3.3. Social
        • 7.2.3.4. Physhological
      • 7.2.4. Global Neurorehabilitation Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Neurorehabilitation: by Type(USD Million)
  • Table 2. Neurorehabilitation Traumatic Brain Injury (TBI) , by Region USD Million (2015-2020)
  • Table 3. Neurorehabilitation Acquired Brain Injury (ABI) , by Region USD Million (2015-2020)
  • Table 4. Neurorehabilitation: by Application(USD Million)
  • Table 5. Neurorehabilitation General Hospital , by Region USD Million (2015-2020)
  • Table 6. Neurorehabilitation Rehabilitation Specialist Hospital , by Region USD Million (2015-2020)
  • Table 7. Neurorehabilitation Community Rehabilitation Center , by Region USD Million (2015-2020)
  • Table 8. Neurorehabilitation: by Rehabilitation(USD Million)
  • Table 9. Neurorehabilitation Medical , by Region USD Million (2015-2020)
  • Table 10. Neurorehabilitation Vocational , by Region USD Million (2015-2020)
  • Table 11. Neurorehabilitation Social , by Region USD Million (2015-2020)
  • Table 12. Neurorehabilitation Physhological , by Region USD Million (2015-2020)
  • Table 13. South America Neurorehabilitation, by Country USD Million (2015-2020)
  • Table 14. South America Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 15. South America Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 16. South America Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 17. South America Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 18. Brazil Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 19. Brazil Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 20. Brazil Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 21. Brazil Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 22. Argentina Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 23. Argentina Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 24. Argentina Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 25. Argentina Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 26. Rest of South America Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 27. Rest of South America Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 28. Rest of South America Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 29. Rest of South America Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 30. Asia Pacific Neurorehabilitation, by Country USD Million (2015-2020)
  • Table 31. Asia Pacific Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 32. Asia Pacific Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 33. Asia Pacific Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 34. Asia Pacific Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 35. China Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 36. China Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 37. China Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 38. China Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 39. Japan Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 40. Japan Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 41. Japan Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 42. Japan Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 43. India Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 44. India Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 45. India Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 46. India Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 47. South Korea Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 48. South Korea Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 49. South Korea Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 50. South Korea Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 51. Taiwan Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 52. Taiwan Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 53. Taiwan Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 54. Taiwan Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 55. Australia Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 56. Australia Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 57. Australia Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 58. Australia Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 59. Rest of Asia-Pacific Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 60. Rest of Asia-Pacific Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 61. Rest of Asia-Pacific Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 63. Europe Neurorehabilitation, by Country USD Million (2015-2020)
  • Table 64. Europe Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 65. Europe Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 66. Europe Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 67. Europe Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 68. Germany Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 69. Germany Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 70. Germany Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 71. Germany Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 72. France Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 73. France Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 74. France Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 75. France Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 76. Italy Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 77. Italy Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 78. Italy Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 79. Italy Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 80. United Kingdom Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 81. United Kingdom Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 82. United Kingdom Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 83. United Kingdom Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 84. Netherlands Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 85. Netherlands Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 86. Netherlands Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 87. Netherlands Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 88. Rest of Europe Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 89. Rest of Europe Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 90. Rest of Europe Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 91. Rest of Europe Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 92. MEA Neurorehabilitation, by Country USD Million (2015-2020)
  • Table 93. MEA Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 94. MEA Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 95. MEA Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 96. MEA Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 97. Middle East Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 98. Middle East Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 99. Middle East Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 100. Middle East Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 101. Africa Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 102. Africa Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 103. Africa Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 104. Africa Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 105. North America Neurorehabilitation, by Country USD Million (2015-2020)
  • Table 106. North America Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 107. North America Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 108. North America Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 109. North America Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 110. United States Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 111. United States Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 112. United States Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 113. United States Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 114. Canada Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 115. Canada Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 116. Canada Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 117. Canada Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 118. Mexico Neurorehabilitation, by Type USD Million (2015-2020)
  • Table 119. Mexico Neurorehabilitation, by Application USD Million (2015-2020)
  • Table 120. Mexico Neurorehabilitation, by Rehabilitation USD Million (2015-2020)
  • Table 121. Mexico Neurorehabilitation, by Components USD Million (2015-2020)
  • Table 122. Company Basic Information, Sales Area and Its Competitors
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Neurorehabilitation: by Type(USD Million)
  • Table 131. Neurorehabilitation Traumatic Brain Injury (TBI) , by Region USD Million (2021-2026)
  • Table 132. Neurorehabilitation Acquired Brain Injury (ABI) , by Region USD Million (2021-2026)
  • Table 133. Neurorehabilitation: by Application(USD Million)
  • Table 134. Neurorehabilitation General Hospital , by Region USD Million (2021-2026)
  • Table 135. Neurorehabilitation Rehabilitation Specialist Hospital , by Region USD Million (2021-2026)
  • Table 136. Neurorehabilitation Community Rehabilitation Center , by Region USD Million (2021-2026)
  • Table 137. Neurorehabilitation: by Rehabilitation(USD Million)
  • Table 138. Neurorehabilitation Medical , by Region USD Million (2021-2026)
  • Table 139. Neurorehabilitation Vocational , by Region USD Million (2021-2026)
  • Table 140. Neurorehabilitation Social , by Region USD Million (2021-2026)
  • Table 141. Neurorehabilitation Physhological , by Region USD Million (2021-2026)
  • Table 142. South America Neurorehabilitation, by Country USD Million (2021-2026)
  • Table 143. South America Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 144. South America Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 145. South America Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 146. South America Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 147. Brazil Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 148. Brazil Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 149. Brazil Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 150. Brazil Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 151. Argentina Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 152. Argentina Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 153. Argentina Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 154. Argentina Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 155. Rest of South America Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 156. Rest of South America Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 157. Rest of South America Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 158. Rest of South America Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 159. Asia Pacific Neurorehabilitation, by Country USD Million (2021-2026)
  • Table 160. Asia Pacific Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 161. Asia Pacific Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 162. Asia Pacific Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 163. Asia Pacific Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 164. China Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 165. China Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 166. China Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 167. China Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 168. Japan Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 169. Japan Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 170. Japan Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 171. Japan Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 172. India Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 173. India Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 174. India Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 175. India Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 176. South Korea Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 177. South Korea Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 178. South Korea Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 179. South Korea Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 180. Taiwan Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 181. Taiwan Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 182. Taiwan Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 183. Taiwan Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 184. Australia Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 185. Australia Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 186. Australia Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 187. Australia Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 188. Rest of Asia-Pacific Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 189. Rest of Asia-Pacific Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 190. Rest of Asia-Pacific Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 191. Rest of Asia-Pacific Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 192. Europe Neurorehabilitation, by Country USD Million (2021-2026)
  • Table 193. Europe Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 194. Europe Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 195. Europe Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 196. Europe Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 197. Germany Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 198. Germany Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 199. Germany Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 200. Germany Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 201. France Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 202. France Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 203. France Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 204. France Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 205. Italy Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 206. Italy Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 207. Italy Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 208. Italy Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 209. United Kingdom Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 210. United Kingdom Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 211. United Kingdom Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 212. United Kingdom Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 213. Netherlands Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 214. Netherlands Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 215. Netherlands Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 216. Netherlands Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 217. Rest of Europe Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 218. Rest of Europe Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 219. Rest of Europe Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 220. Rest of Europe Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 221. MEA Neurorehabilitation, by Country USD Million (2021-2026)
  • Table 222. MEA Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 223. MEA Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 224. MEA Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 225. MEA Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 226. Middle East Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 227. Middle East Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 228. Middle East Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 229. Middle East Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 230. Africa Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 231. Africa Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 232. Africa Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 233. Africa Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 234. North America Neurorehabilitation, by Country USD Million (2021-2026)
  • Table 235. North America Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 236. North America Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 237. North America Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 238. North America Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 239. United States Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 240. United States Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 241. United States Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 242. United States Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 243. Canada Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 244. Canada Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 245. Canada Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 246. Canada Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 247. Mexico Neurorehabilitation, by Type USD Million (2021-2026)
  • Table 248. Mexico Neurorehabilitation, by Application USD Million (2021-2026)
  • Table 249. Mexico Neurorehabilitation, by Rehabilitation USD Million (2021-2026)
  • Table 250. Mexico Neurorehabilitation, by Components USD Million (2021-2026)
  • Table 251. Research Programs/Design for This Report
  • Table 252. Key Data Information from Secondary Sources
  • Table 253. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Neurorehabilitation: by Type USD Million (2015-2020)
  • Figure 5. Global Neurorehabilitation: by Application USD Million (2015-2020)
  • Figure 6. Global Neurorehabilitation: by Rehabilitation USD Million (2015-2020)
  • Figure 7. South America Neurorehabilitation Share (%), by Country
  • Figure 8. Asia Pacific Neurorehabilitation Share (%), by Country
  • Figure 9. Europe Neurorehabilitation Share (%), by Country
  • Figure 10. MEA Neurorehabilitation Share (%), by Country
  • Figure 11. North America Neurorehabilitation Share (%), by Country
  • Figure 12. Global Neurorehabilitation share by Players 2020 (%)
  • Figure 13. Global Neurorehabilitation share by Players (Top 3) 2020(%)
  • Figure 14. Global Neurorehabilitation share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. VISHEE (China) Revenue, Net Income and Gross profit
  • Figure 17. VISHEE (China) Revenue: by Geography 2020
  • Figure 18. Beijing Bo'ai Hospital (China) Revenue, Net Income and Gross profit
  • Figure 19. Beijing Bo'ai Hospital (China) Revenue: by Geography 2020
  • Figure 20. Beijing Rehabilitation Hospital of Capital Medical University (China) Revenue, Net Income and Gross profit
  • Figure 21. Beijing Rehabilitation Hospital of Capital Medical University (China) Revenue: by Geography 2020
  • Figure 22. Tongji Hospital (China) Revenue, Net Income and Gross profit
  • Figure 23. Tongji Hospital (China) Revenue: by Geography 2020
  • Figure 24. DIH (Netherlands) Revenue, Net Income and Gross profit
  • Figure 25. DIH (Netherlands) Revenue: by Geography 2020
  • Figure 26. Xiangyu Medical(China) Revenue, Net Income and Gross profit
  • Figure 27. Xiangyu Medical(China) Revenue: by Geography 2020
  • Figure 28. Sant Joan de Déu (Spain) Revenue, Net Income and Gross profit
  • Figure 29. Sant Joan de Déu (Spain) Revenue: by Geography 2020
  • Figure 30. Clinique Valmont (Switzerland) Revenue, Net Income and Gross profit
  • Figure 31. Clinique Valmont (Switzerland) Revenue: by Geography 2020
  • Figure 32. Global Neurorehabilitation: by Type USD Million (2021-2026)
  • Figure 33. Global Neurorehabilitation: by Application USD Million (2021-2026)
  • Figure 34. Global Neurorehabilitation: by Rehabilitation USD Million (2021-2026)
  • Figure 35. South America Neurorehabilitation Share (%), by Country
  • Figure 36. Asia Pacific Neurorehabilitation Share (%), by Country
  • Figure 37. Europe Neurorehabilitation Share (%), by Country
  • Figure 38. MEA Neurorehabilitation Share (%), by Country
  • Figure 39. North America Neurorehabilitation Share (%), by Country
List of companies from research coverage that are profiled in the study
  • VISHEE (China)
  • Beijing Bo'ai Hospital (China)
  • Beijing Rehabilitation Hospital of Capital Medical University (China)
  • Tongji Hospital (China)
  • DIH (Netherlands)
  • Xiangyu Medical(China)
  • Sant Joan de Déu (Spain)
  • Clinique Valmont (Switzerland)
Select User Access Type

Key Highlights of Report


Apr 2021 218 Pages 77 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Neurorehabilitation Quantitative research analysis
Global Neurorehabilitation Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Neurorehabilitation market is expected to see a growth of % during projected year 2020 to 2026.
The prominent players of Global Neurorehabilitation market are VISHEE (China), Beijing Bo'ai Hospital (China), Beijing Rehabilitation Hospital of Capital Medical University (China), Tongji Hospital (China), DIH (Netherlands), Xiangyu Medical(China), Sant Joan de Déu (Spain) and Clinique Valmont (Switzerland), to name a few.
In this highly competitive & fast evolving Neurorehabilitation industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Global Neurorehabilitation Report?

Have a Query? Click Here

Other Related Reports

Infusion Therapy Comprehensive Study by Type (Intravenous Set, Needleless Catheter, Infusion Pump), Application (Chemotherapy, Diabetes, Hydration Therapy, Inotropic Therapy, Pain Management, HIV, Po...
$ 3750
Hantavirus Comprehensive Study by Type (Sin Nombre, Black Creek Hantavirus, Seoul Virus, New York Hantavirus), Application (Hospitals, Clinics, Intensive Care Unit), Treatment (Mechanical Ventilation...
$ 3650
Edema Clinical Comprehensive Study by Type (Systematic Edema Clinical {Cardiac Disease, Hepatic Disease, Renal Disease, Others}, Local Edema Clinical {Cellulitis, Chronic Venous Insufficiency, Others...
$ 3750
Stereotactic Radiosurgery Comprehensive Study by Application (Brain Tumors, Arteriovenous Malformations (AVMs), Trigeminal Neuralgia, Tremor, Others), End-User (Hospitals, Clinics, Ambulatory Surgery...
$ 3650
Hormone Replacement Therapeutics Comprehensive Study by Type (Estrogen Hormone, Growth Hormone, Thyroid Hormone, Testosterone Hormone), Application (Menopause, Hypothyroidism, Growth Hormone Deficien...
$ 3750
Bone Cancer Treatment Comprehensive Study by Type (Surgery, Chemotherapy, Radiation Therapy, Targeted Therapy, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Dr...
$ 3800